Plus: Teal Health raises $22 million for at-home HPV screening, and the FDA clears a pivotal study of an ovarian cancer screening test.
Xella Health and ŌURA are connecting continuous wearable insights with multi-omic diagnostics and physician-guided care. Members can choose to share Oura trends spanning sleep, heart rate variability, temperature, recovery, activity, and menstrual cycles, giving Xella clinicians longitudinal context alongside diagnostic results and check-ins. The integration is designed to help personalize care across perimenopause, fertility, cardiometabolic health, and longevity. Teal Health’s $22 million Series A follows, alongside the latest in women’s health diagnostics and access. Five takes inside, plus a quick-hits roundup.
Teal Health secured $22 million in Series A funding, led by .406 Ventures. Emerson Collective, Forerunner, Serena Ventures, and MPower Partners also supported the round. Teal Health develops an at-home HPV cervical cancer screening device. This funding advances femtech innovation in preventative care.
Read the full story →The FDA approved an Investigational Device Exemption for Mercy BioAnalytics. This approval allows Mercy BioAnalytics to evaluate its Evident blood-based ovarian cancer screening test in the prospective pivotal SOARA study. The SOARA study will evaluate the Evident test in average-risk women.
Read the full story →Teal Health raised $22 million in Series A funding to expand at-home HPV screening, addressing a gap where 59% of users are underscreened. In early 2027, federal guidelines will require most US health plans to cover self-collection for cervical cancer screening without cost-sharing. Separately, Blair Health secured CAD $4.24 million to scale its specialist women's health model, beginning with menopause care. Nike co-founder Phil Knight and Penny Knight committed $1.1 billion to Providence for Oregon's first dedicated women’s health hospital.
Read the full story →On September 23, 2026, Make Time Wellness expanded access to its women's brain health products by launching with Meijer and returning to QVC. The rapidly growing women's brain health supplement line, founded by Emma Heming, will feature Scientific Advisor Nicole Beurkens, PhD, promoting Brain Health Awareness on QVC. This expansion broadens distribution for a femtech company in the hormonal health sector.
Read the full story →Xella Health and ŌURA launched an integration connecting wearable insights with physician-guided women’s health care. Members can choose to share Oura data—including sleep, HRV, resting heart rate, temperature, recovery, activity, and cycle insights—with Xella. Clinicians can interpret those trends alongside multi-omic diagnostics and ongoing check-ins to personalize care across perimenopause, fertility, cardiometabolic health, and longevity.
Read the full story →